ATS 2018 International Conference - Mobile

Clinical Experience with Telavancin for the Treatment of Monomicrobial Staphylococcus Aureus Lower Respiratory Tract Infections in Patients: Final Results from the Telavancin Observational Use Registry (TOUR™) [Board No. P457]

Location: Board no. P457

Session Type: Thematic Poster Session

Monday

May

21

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Ziba Ansari-Orlando

PharmD
Marin General Hospital

Bibiana Castaneda-Ruiz

MD
Theravance Biopharma US Inc.

Candice Clay

PhD
Theravance Biopharma US Inc.

Dino Delaportas

MD
Mountaineer Infectious Disease LLC

Ryan K. Shields

PharmD
University of of Pittsburgh

Anna Osmukhina

PhD
Theravance Biopharma US Inc.

View Abstract

Clinical Experience with Telavancin for the Treatment of Monomicrobial Staphylococcus Aureus Lower Respiratory Tract Infections in Patients: Final Results from the Telavancin Observational Use Registry (TOUR™)

Parent Sessions

B42 - CRITICAL CARE: THE FEVER - INFECTIONS IN THE ICU...
05-21-2018 9:15 AM - 4:15 PM